Birgit Flechl

436 total citations
24 papers, 306 citations indexed

About

Birgit Flechl is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Birgit Flechl has authored 24 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Birgit Flechl's work include Glioma Diagnosis and Treatment (20 papers), Brain Metastases and Treatment (9 papers) and Cancer-related cognitive impairment studies (7 papers). Birgit Flechl is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Brain Metastases and Treatment (9 papers) and Cancer-related cognitive impairment studies (7 papers). Birgit Flechl collaborates with scholars based in Austria, Germany and Netherlands. Birgit Flechl's co-authors include Christine Marosi, Matthias Preusser, Cornelia Sax, Georg Widhalm, Richard Crevenna, Karin Dieckmann, Karin Dieckmann, Johannes A. Hainfellner, Alexander Gaiger and Mohammad Kéilani and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Radiotherapy and Oncology.

In The Last Decade

Birgit Flechl

22 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Flechl Austria 11 213 113 76 61 50 24 306
Awni Musharbash Jordan 11 144 0.7× 44 0.4× 87 1.1× 56 0.9× 71 1.4× 20 341
Chiara Monagheddu Italy 8 91 0.4× 95 0.8× 34 0.4× 112 1.8× 36 0.7× 11 405
Jeremy M. Schraw United States 11 101 0.5× 78 0.7× 121 1.6× 66 1.1× 148 3.0× 53 470
Heather Leeper United States 11 255 1.2× 103 0.9× 62 0.8× 75 1.2× 25 0.5× 22 444
Shaina Sedighim United States 9 134 0.6× 82 0.7× 44 0.6× 241 4.0× 46 0.9× 26 494
Hanneke Zwinkels Netherlands 7 379 1.8× 178 1.6× 50 0.7× 113 1.9× 185 3.7× 20 562
Michael Scott United States 8 73 0.3× 70 0.6× 53 0.7× 63 1.0× 45 0.9× 22 332
Akanksha Sharma United States 8 91 0.4× 72 0.6× 43 0.6× 41 0.7× 12 0.2× 48 229
Edward K. Avila United States 14 239 1.1× 137 1.2× 18 0.2× 87 1.4× 97 1.9× 26 522
Paola Fidani Italy 13 116 0.5× 119 1.1× 42 0.6× 73 1.2× 36 0.7× 23 472

Countries citing papers authored by Birgit Flechl

Since Specialization
Citations

This map shows the geographic impact of Birgit Flechl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Flechl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Flechl more than expected).

Fields of papers citing papers by Birgit Flechl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Flechl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Flechl. The network helps show where Birgit Flechl may publish in the future.

Co-authorship network of co-authors of Birgit Flechl

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Flechl. A scholar is included among the top collaborators of Birgit Flechl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Flechl. Birgit Flechl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wittig, Andrea, Lisa Deloch, Birgit Flechl, et al.. (2025). Gender parity in radiation oncology in Germany: a 2024 analysis of professional roles and academic training. Strahlentherapie und Onkologie.
2.
Lütgendorf‐Caucig, Carola, Birgit Flechl, Christine Marosi, et al.. (2024). Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1206–1216. 5 indexed citations
3.
Tubin, S., Piero Fossati, Ulrike Mock, et al.. (2023). Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience. Cancers. 15(7). 2093–2093. 3 indexed citations
4.
Flechl, Birgit, et al.. (2022). Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015. International Journal of Radiation Oncology*Biology*Physics. 115(5). 1102–1114. 6 indexed citations
5.
Lütgendorf‐Caucig, Carola, Birgit Flechl, Petra Georg, et al.. (2022). The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy. Strahlentherapie und Onkologie. 199(4). 396–403. 2 indexed citations
6.
Flechl, Birgit, Eugen B. Hug, Razvan Galalae, et al.. (2022). Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes. Frontiers in Oncology. 12. 962697–962697. 1 indexed citations
7.
Handisurya, Ammon, Tamara Rumpold, Birgit Flechl, et al.. (2018). Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma. Radiotherapy and Oncology. 130. 139–148. 11 indexed citations
8.
Flechl, Birgit, Cornelia Sax, Richard Crevenna, et al.. (2017). The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma. Radiotherapy and Oncology. 125(2). 228–233. 22 indexed citations
9.
Hassler, Marco, Cornelia Sax, Birgit Flechl, et al.. (2014). Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma. Oncology. 88(3). 173–179. 11 indexed citations
10.
Hassler, Marco, Birgit Flechl, Cornelia Sax, et al.. (2014). Sorafenib for patients with pretreated recurrent or progressive high-grade glioma. Anti-Cancer Drugs. 25(6). 723–728. 12 indexed citations
11.
Hassler, Marco, Birgit Flechl, Christine Haberler, et al.. (2014). Response to imatinib as a function of target kinase expression in recurrent glioblastoma. SpringerPlus. 3(1). 111–111. 21 indexed citations
12.
Mock, Ulrike, Dietmar Georg, Stanislav Vatnitsky, et al.. (2014). Assessment of improved organ at risk sparing for meningioma: Light ion beam therapy as boost versus sole treatment option. Radiotherapy and Oncology. 111(3). 451–456. 3 indexed citations
13.
Koekkoek, Johan A F, Linda Dirven, Jaap C. Reijneveld, et al.. (2014). End of life care in high-grade glioma patients in three European countries: a comparative study. Journal of Neuro-Oncology. 120(2). 303–310. 32 indexed citations
14.
Flechl, Birgit, Karin Dieckmann, Matthias Preusser, et al.. (2014). Outcome evaluation in glioblastoma patients older than 65 years: Importance of individual assessment of treatment tolerance. Clinical Neuropathology. 33(11). 399–406. 5 indexed citations
15.
Flechl, Birgit, Cornelia Sax, Stefan Oberndorfer, et al.. (2013). The caregivers’ perspective on the end-of-life phase of glioblastoma patients. Journal of Neuro-Oncology. 112(3). 403–411. 62 indexed citations
16.
Flechl, Birgit, Richard Crevenna, Mohammad Kéilani, et al.. (2013). The Association of Early Cognition Assessments and Progression-free Survival in Patients with Glioblastoma Multiforme. 1(4). 1–9. 2 indexed citations
17.
Flechl, Birgit & Christine Marosi. (2013). Austrian Patients with Glioblastoma Multiforme and Their Families: Socioeconomic Aspects. 3(2). 46–48. 3 indexed citations
18.
Kéilani, Mohammad, Christoph Krall, Christine Marosi, et al.. (2012). Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients. Wiener klinische Wochenschrift. 124(11-12). 377–383. 17 indexed citations
19.
Flechl, Birgit, Cornelia Sax, Karin Dieckmann, et al.. (2012). Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. Journal of Neuro-Oncology. 109(2). 331–339. 39 indexed citations
20.
Flechl, Birgit, Adelheid Wöhrer, Georg Widhalm, et al.. (2012). Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO). Neuro-Oncology. 15(1). 112–121. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Awni Musharbash Breakdown of academic impact, for papers by Chiara Monagheddu Breakdown of academic impact, for papers by Jeremy M. Schraw Breakdown of academic impact, for papers by Heather Leeper Breakdown of academic impact, for papers by Shaina Sedighim Breakdown of academic impact, for papers by Hanneke Zwinkels Breakdown of academic impact, for papers by Michael Scott Breakdown of academic impact, for papers by Akanksha Sharma Breakdown of academic impact, for papers by Edward K. Avila Breakdown of academic impact, for papers by Paola Fidani
Rankless by CCL
2026